-
Signature
-
/s/ Jeffrey Trigilio, Attorney-in-Fact
-
Stock symbol
-
CGEM
-
Transactions as of
-
Sep 8, 2021
-
Transactions value $
-
-$265,650
-
Form type
-
4
-
Date filed
-
9/9/2021, 04:15 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CGEM |
Common Stock |
Options Exercise |
$47.3K |
+11K |
|
$4.30 |
11K |
Sep 8, 2021 |
Direct |
|
transaction |
CGEM |
Common Stock |
Sale |
-$313K |
-11K |
-100% |
$28.45 |
0 |
Sep 8, 2021 |
Direct |
F1 |
holding |
CGEM |
Common Stock |
|
|
|
|
|
341K |
Sep 8, 2021 |
See Footnote |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CGEM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-11K |
-4.38% |
$0.00 |
240K |
Sep 8, 2021 |
Common Stock |
11K |
$4.30 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Acting Chief Scientific Officer, Biologics